MLchartDataset catalogue

anti-DLL3 CAR-NK cells SNC-115

Term · Oncology and biomedicine · MLC-T-ONC-010575

A preparation of natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) delta-like protein 3 (DLL3), with potential immunomodulating and antineoplastic activities. Upon administration, anti-DLL3 CAR-NK cells SNC-115 recognize, bind to and induce selective cytotoxicity in DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.

Table 1. Record
IdentifierMLC-T-ONC-010575
FieldOncology and biomedicine
Synonymsanti-DLL3 CAR NK cells SNC-115; anti-DLL3 CAR-natural killer cells SNC-115
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010575",
  "term": "anti-DLL3 CAR-NK cells SNC-115",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) delta-like protein 3 (DLL3), with potential immunomodulating and antineoplastic activities. Upon administration, anti-DLL3 CAR-NK cells SNC-115 recognize, bind to and induce selective cytotoxicity in DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.",
  "synonyms": [
    "anti-DLL3 CAR NK cells SNC-115",
    "anti-DLL3 CAR-natural killer cells SNC-115"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-dll3-car-nk-cells-snc-115/"
}

Record 1,671 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.